Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease
Joint Authors
Schoenberger, Scott D.
Kim, Stephen J.
Source
International Journal of Inflammation
Issue
Vol. 2013, Issue 2013 (31 Dec. 2013), pp.1-8, 8 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2013-01-14
Country of Publication
Egypt
No. of Pages
8
Main Subjects
Abstract EN
Nonsteroidal anti-inflammatory drugs (NSAIDs) are used extensively in ophthalmology for pain and photophobia after photorefractive surgery and to reduce miosis, inflammation, and cystoid macular edema following cataract surgery.
In recent years, the US Food and Drug Administration has approved new topical NSAIDs and previously approved NSAIDs have been reformulated.
These changes may allow for greater drug penetration into the retina and thereby offer additional therapeutic advantages.
For example, therapeutic effects on diabetic retinopathy and age-related macular degeneration may now be achievable.
We provide an updated review on the scientific rationale and clinical use of NSAIDs for retinal disease.
American Psychological Association (APA)
Schoenberger, Scott D.& Kim, Stephen J.. 2013. Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease. International Journal of Inflammation،Vol. 2013, no. 2013, pp.1-8.
https://search.emarefa.net/detail/BIM-460067
Modern Language Association (MLA)
Schoenberger, Scott D.& Kim, Stephen J.. Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease. International Journal of Inflammation No. 2013 (2013), pp.1-8.
https://search.emarefa.net/detail/BIM-460067
American Medical Association (AMA)
Schoenberger, Scott D.& Kim, Stephen J.. Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease. International Journal of Inflammation. 2013. Vol. 2013, no. 2013, pp.1-8.
https://search.emarefa.net/detail/BIM-460067
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-460067